Psychedelics MindBio Therapeutics uses AI speech analysis to see if you’ve taken its LSD drug The biopharma operator's lead drug candidate, MB22001, was created for microdosing Rowan DunneJanuary 24, 2025
Psychedelics University College London undertakes extensive DMT study aimed at treating alcohol abuse The renowned institution claims this is the largest-ever psychedelic brain imaging study of its variety Rowan DunneJanuary 20, 2025
Psychedelics Denver Shroom Fest set to return after successful debut in 2024 Last year's event was a vibe Rowan DunneJanuary 16, 2025
Medical and Pharmaceutical SILO Pharma flies high on impending patent for intranasal PTSD drug The stock rose by 146% in early morning trading on the Nasdaq Rowan DunneJanuary 8, 2025
Psychedelics Colorado set to ring in new year with regulated magic mushroom therapy A law passed by voters in late 2022 is coming into force on Jan. 1 Rowan DunneDecember 30, 2024
AI and Autonomy The Best of 2024: A Mugglehead roundup The year’s economic landscape as 2024 comes to a close demonstrates the resilience and adaptability of key sectors Joseph MortonDecember 30, 2024
Psychedelics Psychedelic YouTuber Willy Myco drops world’s first LSD synthesizing tutorial vid He travelled all the way to Pakistan to make the video without facing legal consequences Rowan DunneDecember 23, 2024
Psychedelics Psychedelic drug developer MindMed set for listing on Nasdaq Biotechnology Index MindMed's lead drug candidate is an LSD-like therapeutic used to treat anxiety Rowan DunneDecember 20, 2024
Psychedelics Pope Francis lobbied for psychedelic reformation at newly disclosed Vatican meeting He met with New Testament critic Brian Muraresku in late 2021/early 2022, but nobody heard until now Rowan DunneDecember 19, 2024
Psychedelics San Francisco psychedelic church shuts down over hostility from city officials The Church of Ambrosia's primary location in Oakland will continue its mushroom worship Rowan DunneDecember 11, 2024